Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adaptive Biotechnologies Corp
(NQ:
ADPT
)
8.270
+0.240 (+2.99%)
Streaming Delayed Price
Updated: 1:24 PM EDT, Mar 21, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
266,715
Open
8.140
Bid (Size)
8.260 (4)
Ask (Size)
8.280 (4)
Prev. Close
8.030
Today's Range
7.920 - 8.340
52wk Range
5.955 - 15.19
Shares Outstanding
143,226,757
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Adaptive Biotechnologies to Participate in the 43rd Annual Cowen Healthcare Conference
February 27, 2023
From
Adaptive Biotechnologies
Via
Globe NewsWire
Trade Desk, Roblox, Herbalife And Other Big Stocks Moving Higher On Wednesday
February 15, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Performance
YTD
+6.03%
+6.03%
1 Month
-6.02%
-6.02%
3 Month
+13.91%
+13.91%
6 Month
+6.16%
+6.16%
1 Year
-34.62%
-34.62%
More News
Read More
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results
February 14, 2023
From
Adaptive Biotechnologies
Via
Globe NewsWire
What To Know About Piper Sandler's Upgrade of Adaptive Biotechnologies
December 21, 2022
Via
Benzinga
Looking Into Adaptive Biotechnologies's Return On Capital Employed
November 25, 2022
Via
Benzinga
Expert Ratings for Adaptive Biotechnologies
November 07, 2022
Via
Benzinga
Earnings Scheduled For February 14, 2023
February 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 13, 2023
Via
Benzinga
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023
January 23, 2023
From
Adaptive Biotechnologies
Via
Globe NewsWire
Adaptive Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 27, 2022
From
Adaptive Biotechnologies
Via
Globe NewsWire
Nike, FedEx And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
December 21, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
December 21, 2022
Via
Benzinga
Adaptive Biotechnologies Highlights New Data Showcasing the Clinical Utility of clonoSEQ® MRD Testing in Patients with Blood Cancers at the 64th ASH Annual Meeting
December 10, 2022
From
Adaptive Biotechnologies
Via
Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
December 21, 2022
Via
Benzinga
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Clinical Utility and Benefit of clonoSEQ® MRD Testing in Blood Cancer Patients at 2022 ASH Annual Meeting
December 05, 2022
From
Adaptive Biotechnologies
Via
Globe NewsWire
Adaptive Biotechnologies Announces Launch of clonoSEQ® to Assess Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using Circulating Tumor DNA (ctDNA)
December 01, 2022
From
Adaptive Biotechnologies
Via
Globe NewsWire
Adaptive Biotechnologies to Participate in the Piper Sandler Healthcare Conference
November 21, 2022
From
Adaptive Biotechnologies
Via
Globe NewsWire
New Survey Reveals the Majority of Myeloma Patients That Undergo Minimal Residual Disease (MRD) Testing Find a Clear Clinical or Emotional Benefit from Results
November 21, 2022
From
Adaptive Biotechnologies
Via
Globe NewsWire
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
Via
Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
November 08, 2022
Via
Benzinga
5 Top Stocks Cathie Wood Is Buying This Week
November 04, 2022
Via
InvestorPlace
Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Adaptive Biotechnologies
Via
Globe NewsWire
General Electric To Surge Around 27%? Plus This Analyst Predicts $44 For General Motors
October 26, 2022
Via
Benzinga
Adaptive Announces Partnership with Epic to Increase Access to Minimal Residual Disease (MRD) Monitoring in Blood Cancers
October 11, 2022
From
Adaptive Biotechnologies
Via
Globe NewsWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.